UPH · Uphealth, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | - | $32.68M | $37.82M | $42.15M | - | $38.67M | $43.67M | $35.97M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | $0 | - | $17.62M | $19.98M | $22.68M | - | $18.50M | $22.39M | $15.30M | - |
| R&D | $21.0K | - | $1.98M | $848.0K | $1.28M | - | $2.23M | $1.78M | $1.59M | - |
| SG&A | $3.99M | - | $8.82M | $12.77M | $11.01M | - | $13.92M | $14.63M | $13.66M | - |
| Total Operating Expenses | $5.37M | - | $90.41M | $30.72M | $23.45M | - | $138.53M | $32.44M | $9.77M | - |
| D&A | $170.0K | - | $1.83M | $1.74M | $2.41M | - | $3.34M | $4.70M | $922.0K | - |
| Operating Income | ($5.37M) | - | ($72.79M) | ($10.74M) | ($778.0K) | - | ($120.03M) | ($10.04M) | ($17.91M) | - |
| Interest Expense | $5.53M | - | $6.71M | $7.14M | $6.86M | - | $6.71M | $6.60M | $7.00M | - |
| Income Tax | $4.52M | - | $0 | $867.0K | $0 | - | ($13.22M) | ($2.23M) | ($2.29M) | - |
| Net Income | $25.42M | - | ($20.61M) | ($19.13M) | ($8.08M) | - | ($165.76M) | ($12.44M) | ($17.45M) | - |
| EPS - Basic | $1.36 | - | ($1.12) | ($1.05) | ($0.51) | - | ($11.17) | ($0.09) | ($0.12) | - |
| EPS - Diluted | $1.36 | - | ($1.12) | ($1.05) | ($0.51) | - | ($11.17) | ($0.09) | ($0.42) | - |
Balance Sheet
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $955.0K | $2.55M | $3.34M | $46.80M | $13.33M | $15.56M | $22.61M | $40.63M | $52.04M | $58.19M |
| Accounts Receivable | - | $14.66M | $16.53M | $22.37M | $24.43M | $21.85M | $22.63M | $28.66M | $19.55M | $22.76M |
| Inventory | - | $0 | $0 | $18.0K | $134.0K | $161.0K | $2.76M | $2.97M | $3.08M | $2.93M |
| Accounts Payable | $3.74M | $11.72M | $5.19M | $12.69M | $17.26M | $17.98M | $16.39M | $18.16M | $14.76M | $13.60M |
| Current Assets | $171.91M | $20.21M | $22.01M | $71.31M | $44.34M | $43.32M | $52.09M | $76.58M | $97.93M | $106.75M |
| Total Assets | $269.73M | $231.81M | $235.14M | $295.08M | $338.80M | $339.80M | $345.41M | $520.21M | $548.74M | $569.31M |
| Current Liabilities | $145.53M | $26.83M | $166.37M | $59.98M | $69.37M | $68.97M | $66.65M | $90.23M | $101.54M | $96.70M |
| Long-term Debt | $37.27M | $146.52M | $0 | $141.25M | $148.62M | $145.96M | $143.30M | $105.24M | $101.81M | $98.42M |
| Total Liabilities | $187.95M | $176.70M | $171.01M | $209.66M | $235.20M | $233.67M | $213.93M | $219.33M | $232.67M | $235.46M |
| Stockholders' Equity | $81.78M | $55.10M | $64.13M | $84.14M | $102.21M | $105.15M | $130.67M | $285.96M | $300.95M | $318.46M |
| Retained Earnings | ($598.63M) | ($624.05M) | ($614.02M) | ($593.42M) | ($574.29M) | ($566.21M) | ($538.85M) | ($373.09M) | ($360.65M) | ($343.21M) |
Cash Flow
| Line item | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($6.57M) | - | - | - | ($4.04M) | - | - | - | ($3.07M) | - |
| Investing Cash Flow | $175.00M | - | - | - | ($1.34M) | - | - | - | ($1.66M) | - |
| Financing Cash Flow | ($635.0K) | - | - | - | $3.16M | - | - | - | ($1.02M) | - |
| CapEx | $0 | - | - | - | $1.34M | - | - | - | $8.0K | - |
| Free Cash Flow | ($6.57M) | - | - | - | ($5.38M) | - | - | - | ($3.08M) | - |
Ratios
| Metric | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | 53.9% | 52.8% | 53.8% | - | 47.8% | 51.3% | 42.5% | - |
| Operating margin | - | - | -222.7% | -28.4% | -1.8% | - | -310.4% | -23.0% | -49.8% | - |
| EBITDA margin | - | - | -217.1% | -23.8% | 3.9% | - | -301.8% | -12.2% | -47.2% | - |
| Net margin | - | - | -63.0% | -50.6% | -19.2% | - | -428.7% | -28.5% | -48.5% | - |
| Free cash flow margin | - | - | - | - | -12.8% | - | - | - | -8.6% | - |
| FCF / Net income | -0.26 | - | - | - | 0.67 | - | - | - | 0.18 | - |
| R&D / Revenue | - | - | 6.1% | 2.2% | 3.0% | - | 5.8% | 4.1% | 4.4% | - |
| SG&A / Revenue | - | - | 27.0% | 33.7% | 26.1% | - | 36.0% | 33.5% | 38.0% | - |
| Effective tax rate | 15.1% | - | - | - | - | - | - | - | - | - |
| Return on assets | 9.4% | - | -8.8% | -6.5% | -2.4% | - | -48.0% | -2.4% | -3.2% | - |
| Return on equity | 31.1% | - | -32.1% | -22.7% | -7.9% | - | -126.9% | -4.3% | -5.8% | - |
| Return on invested capital | -3.8% | - | -89.7% | -3.8% | -0.2% | - | -34.6% | -2.0% | -3.5% | - |
| Liquidity | ||||||||||
| Current ratio | 1.18 | 0.75 | 0.13 | 1.19 | 0.64 | 0.63 | 0.78 | 0.85 | 0.96 | 1.10 |
| Quick ratio | 1.18 | 0.75 | 0.13 | 1.19 | 0.64 | 0.63 | 0.74 | 0.82 | 0.93 | 1.07 |
| Cash ratio | 0.01 | 0.09 | 0.02 | 0.78 | 0.19 | 0.23 | 0.34 | 0.45 | 0.51 | 0.60 |
| Leverage | ||||||||||
| Debt / Equity | 0.46 | 2.66 | 0.00 | 1.68 | 1.45 | 1.39 | 1.10 | 0.37 | 0.34 | 0.31 |
| Debt / Assets | 0.14 | 0.63 | 0.00 | 0.48 | 0.44 | 0.43 | 0.41 | 0.20 | 0.19 | 0.17 |
| Debt / EBITDA | - | - | - | - | 90.96 | - | - | - | - | - |
| Interest coverage | -1.0x | - | -10.8x | -1.5x | -0.1x | - | -17.9x | -1.5x | -2.6x | - |
| Equity multiplier | 3.30 | 4.21 | 3.67 | 3.51 | 3.31 | 3.23 | 2.64 | 1.82 | 1.82 | 1.79 |
| Liabilities / Assets | 0.70 | 0.76 | 0.73 | 0.71 | 0.69 | 0.69 | 0.62 | 0.42 | 0.42 | 0.41 |
| Efficiency | ||||||||||
| Asset turnover | 0.00 | - | 0.14 | 0.13 | 0.12 | - | 0.11 | 0.08 | 0.07 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | 185d | 216d | 212d | - | 214d | 240d | 198d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -100.0% | - | -15.5% | -13.4% | 17.2% | - | - | 37.0% | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | -4.7% | -10.8% | 48.2% | - | - | - | - | - |
| Operating income growth (YoY) | -590.2% | - | 39.4% | -6.9% | 95.7% | - | -4105.7% | 71.7% | -1002.8% | - |
| Net income growth (YoY) | - | - | 87.6% | -53.8% | 53.7% | - | - | 62.1% | -1762.6% | - |
| EPS growth (YoY) | - | - | 90.0% | -1066.7% | -21.4% | - | - | -800.0% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -22.2% | - | - | - | -74.7% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -20.0% | -47.6% | -50.9% | -70.6% | -66.0% | -67.0% | -78.7% | -50.6% | 5919.0% | 6269.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Business segments
$130.00M totalVirtual Care Infrastructure Segment$70.15M · 54.0%
Services Segment$47.23M · 36.3%
Integrated Care Management Segment$12.62M · 9.7%
Product / service
$240.04M totalService$110.04M · 45.8%
Service Other$110.04M · 45.8%
Product$13.41M · 5.6%
License And Service$6.55M · 2.7%
Geographic
$130.00M totalAmericas$130.00M · 100.0%
Peer comparison
Same SIC group: Services-Health Services
Comparing UpHealth against the 5 most active filers in the same SIC group.